CHRS Cost of Revenue
Coherus Oncology Inc · Cost of Revenue
CHRS Cost of Revenue
Latest reported$18.57Mperiod ending
CHRS Cost of Revenue ($34.89M → $18.57M)
Annual cost of revenue
High-resolution chart · PNG
CHRS cost of revenue history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Cost of Revenue (USD) |
|---|---|
| 17,738,000 | |
| 117,553,000 | |
| 158,992,000 | |
| 70,083,000 | |
| 57,591,000 | |
| 37,667,000 | |
| 17,078,000 | |
| 3,235,000 | |
| 160,531,000 | |
| 254,440,000 | |
| 212,680,000 | |
| 78,224,000 | |
| 31,279,000 | |
| 34,886,000 |